| Detected | Trial | Change |
|---|---|---|
| 2026-08-09 | NCT06317324 Compare the Prognostic Differences Between SBRT and Surgery for NSCLC Patients With… |
overall status: Recruiting → Unknown |
| 2026-08-09 | NCT04967976 Breast Mesh Used in Two-staged Breast Reconstruction |
overall status: Recruiting → Unknown |
| 2026-08-06 | NCT07475026 A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of… |
Recruitment opened |
| 2026-08-02 | NCT06495515 Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced… |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-02 | NCT06492447 Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing… |
overall status: Not Yet Recruiting → Unknown |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-07 | NCT07751367 A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin… | Not Yet Recruiting | |
| 2026-07-30 | NCT07736001 A Single-arm, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy… | Not Yet Recruiting | |
| 2026-07-30 | NCT07738042 To Explore a Single-arm Phase II Study on Intestinal Microbiota Transplantation Combined… | Not Yet Recruiting | |
| 2026-07-30 | NCT07738055 Study on the Combined Treatment of Hepatocellular Carcinoma With Envafolimab, Suvemcitug… | Not Yet Recruiting | |
| 2026-07-29 | NCT07733830 Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC | Phase 2 | Recruiting |
| 2026-07-27 | NCT07729033 A Phase II Exploratory Study of Sacituzumab Tirumotecan Combined With Envafolimab for… | Phase 2 | Not Yet Recruiting |
| 2026-07-24 | NCT07724782 Multi-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCL | Phase 1/2 | Not Yet Recruiting |
| 2026-07-24 | NCT07726433 Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINV | Phase 2 | Recruiting |
| 2026-07-24 | NCT07726446 Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors | Phase 2 | Recruiting |
| 2026-07-23 | NCT07723729 Butyrate Yogurt for Cancer Constipation | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05035147 | Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer | Pancreatic Cancer | Recruiting |
| NCT07254416 | A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients | Breast Cancer Patients Treated With T-DXd | Not Yet Recruiting |
| NCT07302841 | Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer | Pancreatic Cancer Non-resectable | Not Yet Recruiting |
| Phase 3 | |||
| NCT04807673 | Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT07350928 | Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal… | Breast Cancer | Recruiting |
| NCT07632118 | Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following… | Pancreatic Cancer | Recruiting |
| NCT07436741 | Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in… | Pancreatic Cancer, Adult | Recruiting |
| NCT07475026 | A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of… | HCC - Hepatocellular Carcinoma | Recruiting |
| NCT05678933 | AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH | Peripheral T-cell Lymphoma Targeted Therapy | Enrolling by Invitation |
| NCT06704620 | Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor… | Advanced and Metastatic NSCLC | Not Yet Recruiting |
| NCT07246330 | Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After… | Esophageal Squamous Cell Carcinoma (ESCC) | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT06409429 | Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer | Pancreatic Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT04908566 | Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative… | Locally Advanced Gastric Adenocarcinoma | Recruiting |
| NCT05595590 | Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer | Head and Neck Cancer | Recruiting |
| NCT05651672 | Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations | Gastrointestinal Cancer | Recruiting |
| NCT05686434 | Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR) | NSCLC, Stage I | Recruiting |
| NCT06061146 | Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC | Esophageal Cancer | Recruiting |
| NCT06363734 | Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant… | Non-small Cell Lung Cancer | Recruiting |
| NCT06383559 | Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced… | Gastric Cancer | Recruiting |
| NCT06506292 | A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally… | Adebrelimab (SHR-1316) | Recruiting |
| NCT06560528 | Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative… | Gastric Cancer | Recruiting |
| NCT06141226 | Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined… | Non-small-cell Lung Cancer | Recruiting |
| NCT06301399 | Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy &… | Advanced Hepatocellular Carcinoma | Recruiting |
| NCT06704555 | Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky… | Follicular Lymphoma | Recruiting |
| NCT06721286 | Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant… | Intrahepatic Cholangiocarcinoma (Icc) | Recruiting |